This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: Janssen Pharmaceutica Nv. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Nicolas Freddy J Darville: Innovator in Pharmaceutical Chemistry
Introduction
Nicolas Freddy J Darville is a notable inventor based in Linkhout, Belgium. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work at Janssen Pharmaceutica NV. His expertise and dedication to research have led to the development of valuable patents that enhance medical science.
Latest Patents
One of Darville's key patents is titled "Substituted Straight Chain Spiro Derivatives." This patent showcases his innovative approach to creating new chemical compounds that can potentially lead to advancements in drug development and therapeutic applications. He holds 1 patent in this area, reflecting his commitment to innovation in pharmaceuticals.
Career Highlights
Throughout his career, Darville has been associated with Janssen Pharmaceutica NV, a leading company in the pharmaceutical industry. His work has contributed to the company's reputation for developing cutting-edge medical solutions. His role in the organization highlights his importance in the field of pharmaceutical research and development.
Collaborations
Darville has collaborated with esteemed colleagues such as Wei Cai and Xuedong Dai. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of research and innovation within the company.
Conclusion
Nicolas Freddy J Darville is a distinguished inventor whose work in pharmaceutical chemistry has made a significant impact. His patent on substituted straight chain spiro derivatives exemplifies his innovative spirit and dedication to advancing medical science. His collaborations with other experts further underscore his commitment to excellence in research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
